首页> 外文期刊>Panminerva medica >Novel insights on lymphoma and lymphomagenesis in primary Sj?gren's Syndrome.
【24h】

Novel insights on lymphoma and lymphomagenesis in primary Sj?gren's Syndrome.

机译:关于原发性 Sj?gren 综合征淋巴瘤和淋巴瘤发生的新见解。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Primary Sj?gren's Syndrome (pSS) is a systemic autoimmune disease characterized by a chronic inflammatory process mainly affecting the exocrine glands but also burdened by a wide range of extraglandular manifestations. Non-Hodgkin lymphoma (NHL) is the most severe pSS complication worsening disease prognosis. We summarized original articles published between April 2018 and May 2020 on this topic aiming to highlight novelties on lymphoma and lymphomagenesis. Results have been grouped by epidemiology, etiopathogenesis and predictors of lymphoma. NHL is the most severe complication of pSS and occurs in around 5-10 of patients. Over the last two years, several clinical, serological, and histopathological features have been proposed as predictive for lymphoma in pSS patients, allowing early diagnosis and consequently, better management and prognosis. Individual monitoring for disease activity and possible lymphoma development is a central clue in the evaluation of pSS patients.
机译:原发性干燥综合征 (pSS) 是一种全身性自身免疫性疾病,其特征是主要影响外分泌腺的慢性炎症过程,但也伴有多种腺体外表现。非霍奇金淋巴瘤 (NHL) 是最严重的 pSS 并发症,可使疾病预后恶化。我们总结了 2018 年 4 月至 2020 年 5 月期间发表的关于该主题的原创文章,旨在突出淋巴瘤和淋巴瘤发生的新颖性。结果已按淋巴瘤的流行病学、病因发病机制和预测因素进行分组。NHL 是 pSS 最严重的并发症,发生在大约 5-10% 的患者中。在过去的两年中,已经提出了几种临床、血清学和组织病理学特征作为 pSS 患者淋巴瘤的预测,从而可以早期诊断,从而更好地管理和预后。对疾病活动度和可能的淋巴瘤发展进行个体监测是评估 pSS 患者的核心线索。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号